EDITORIAL - Heterologous vaccine

As recommended by the World Health Organisation (WHO) and National Immunisation Advisory Committee, the Ministry of Health and Population on Tuesday decided to use Covishield/AstraZeneca vaccine as a booster dose for people above 60 years of age even though they had received other doses – Moderna, Pfizer or VeroCell – during the first and second shots.

सम्बन्धित सामग्री